Cargando…
Editorial: Role of the IL-23/IL-17 Pathway in Chronic Immune-Mediated Inflammatory Diseases: Mechanisms and Targeted Therapies
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496837/ https://www.ncbi.nlm.nih.gov/pubmed/34630440 http://dx.doi.org/10.3389/fimmu.2021.770275 |
| _version_ | 1784579835247460352 |
|---|---|
| author | Bianchi, Elisabetta Vecellio, Matteo Rogge, Lars |
| author_facet | Bianchi, Elisabetta Vecellio, Matteo Rogge, Lars |
| author_sort | Bianchi, Elisabetta |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8496837 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84968372021-10-08 Editorial: Role of the IL-23/IL-17 Pathway in Chronic Immune-Mediated Inflammatory Diseases: Mechanisms and Targeted Therapies Bianchi, Elisabetta Vecellio, Matteo Rogge, Lars Front Immunol Immunology Frontiers Media S.A. 2021-09-23 /pmc/articles/PMC8496837/ /pubmed/34630440 http://dx.doi.org/10.3389/fimmu.2021.770275 Text en Copyright © 2021 Bianchi, Vecellio and Rogge https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Immunology Bianchi, Elisabetta Vecellio, Matteo Rogge, Lars Editorial: Role of the IL-23/IL-17 Pathway in Chronic Immune-Mediated Inflammatory Diseases: Mechanisms and Targeted Therapies |
| title | Editorial: Role of the IL-23/IL-17 Pathway in Chronic Immune-Mediated Inflammatory Diseases: Mechanisms and Targeted Therapies |
| title_full | Editorial: Role of the IL-23/IL-17 Pathway in Chronic Immune-Mediated Inflammatory Diseases: Mechanisms and Targeted Therapies |
| title_fullStr | Editorial: Role of the IL-23/IL-17 Pathway in Chronic Immune-Mediated Inflammatory Diseases: Mechanisms and Targeted Therapies |
| title_full_unstemmed | Editorial: Role of the IL-23/IL-17 Pathway in Chronic Immune-Mediated Inflammatory Diseases: Mechanisms and Targeted Therapies |
| title_short | Editorial: Role of the IL-23/IL-17 Pathway in Chronic Immune-Mediated Inflammatory Diseases: Mechanisms and Targeted Therapies |
| title_sort | editorial: role of the il-23/il-17 pathway in chronic immune-mediated inflammatory diseases: mechanisms and targeted therapies |
| topic | Immunology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496837/ https://www.ncbi.nlm.nih.gov/pubmed/34630440 http://dx.doi.org/10.3389/fimmu.2021.770275 |
| work_keys_str_mv | AT bianchielisabetta editorialroleoftheil23il17pathwayinchronicimmunemediatedinflammatorydiseasesmechanismsandtargetedtherapies AT vecelliomatteo editorialroleoftheil23il17pathwayinchronicimmunemediatedinflammatorydiseasesmechanismsandtargetedtherapies AT roggelars editorialroleoftheil23il17pathwayinchronicimmunemediatedinflammatorydiseasesmechanismsandtargetedtherapies |